Transcription factors in parathyroid development: Lessons from hypoparathyroid disorders

Annals of the New York Academy of Sciences

Volumn 1237, Issue 1, 2011, Pages 24-38

  Grigorieva, Irina V ^a   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Congenital; Embryonic development; Hypocalcemia; Parathyroid hormone

Indexed keywords

CYCLIC AMP; DOPAMINE; HOX PROTEIN; LEVODOPA; NORADRENALIN; PAIRED BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX9; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR SIX1; TRANSCRIPTION FACTOR SOX3;

ADDISON DISEASE; AMPHIBIA; ANEMIA; ARTICLE; CANDIDIASIS; CELL DIFFERENTIATION; CELL STRAIN HEK293; CHROMOSOME 10P; DIGEORGE SYNDROME; EAR MALFORMATION; ECTODERM; GENE DELETION; GENE MUTATION; HAPLOINSUFFICIENCY; HEARING IMPAIRMENT; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; KIDNEY DYSPLASIA; MARE; MENTAL DEFICIENCY; NEURAL CREST CELL; NONHUMAN; NOSE MALFORMATION; THYMUS;

EID: 81255176537     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06221.x     Document Type: Article

References (114)

1. Okabe, M. & A. Graham 2004. The origin of the parathyroid gland. Proc. Natl. Acad. Sci. U.S.A. 101: 17716-17719.
2. Gray, H. 2004. Gray's Anatomy: The Anatomical Basis of Medicine and Surgery. 39th ed. Churchill-Livingstone. Edinburgh
3. Graham, A., M. Okabe & R. Quinlan 2005. The role of the endoderm in the development and evolution of the pharyngeal arches. J. Anat. 207: 479-487.
4. Aybar, M.J. & R. Mayor 2002. Early induction of neural crest cells: lessons learned from frog, fish and chick. Curr. Opin. Genet. Dev. 12: 452-458.
5. Manley, N.R. & M.R. Capecchi 1995. The role of Hoxa-3 in mouse thymus and thyroid development. Development. 121: 1989-2003.
6. Moore-Scott, B.A. & N.R. Manley 2005. Differential expression of Sonic hedgehog along the anterior-posterior axis regulates patterning of pharyngeal pouch endoderm and pharyngeal endoderm-derived organs. Dev. Biol. 278: 323-335.
7. Patel, S.R., J. Gordon, F. Mahbub, et al 2006. Bmp4 and Noggin expression during early thymus and parathyroid organogenesis. Gene Expr. Patterns. 6: 794-799.
8. Manley, N.R. & M.R. Capecchi 1998. Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Dev. Biol. 195: 1-15.
9. Manley, N.R. & C.C. Blackburn 2003. A developmental look at thymus organogenesis: where do the non-hematopoietic cells in the thymus come from? Curr. Opin. Immunol. 15: 225-232.
10. Blackburn, C.C. & N.R. Manley 2004. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 4: 278-289.
11. Liu, Z., S. Yu & N.R. Manley 2007. Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid/thymus primordia. Dev. Biol. 305: 333-346.
12. Thakker, R.V. 2009. Genetic regulation of parathyroid gland development. In Principles of Bone Biology, 3rd ed. J.P. Bilezikian, L.G. Raisz & T.J. Martin, Eds.: 1415-1429. Academic Press. San Diego, CA
13. Sharma, A., H. Juppner, R.V. Thakker 2009. Genetic disorders of calcium homeostasis. In Pediatric Nephrology. E. Avner, W. Harmon, P. Niaudet & N. Yoshikawa, Eds.: 267-305. Springer. Berlin
14. Thakker, R.V., F.R. Bringhurst & H. Juppner 2010. Genetic disorders of calcium homeostasis caused by abnormal regulation of parathyroid hormone secretion or responsiveness. In Endocrinology. 6th ed. L.J. DeGroot & J.L. Jameson, Eds.: 1136-1159. Elsevier. Philadelphia, PA
15. Thakker, R.V. 2010. Parathyroid disorders and diseases affecting calcium homeostasis. In Oxford Textbook of Medicine. 5th ed. D.A. Warrell, T.M. Cox, & J.D. Firth, Eds.: 1851-1868. Oxford University Press. United Kingdom
16. Hay, B.N. 2007. Deletion 22q11: spectrum of associated disorders. Semin. Pediatr. Neurol. 14: 136-139.
17. Scambler, P.J., A.H. Carey, R.K. Wyse, et al 1991. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics. 10: 201-206.
18. Monaco, G., C. Pignata, E. Rossi, et al 1991. DiGeorge anomaly associated with 10p deletion. Am. J. Med. Genet. 39: 215-216.
19. Gong, W., B.S. Emanuel, J. Collins, et al 1996. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum. Mol. Genet. 5: 789-800.
20. Scambler, P.J. 2000. The 22q11 deletion syndromes. Hum. Mol. Genet. 9: 2421-2426.
21. Augusseau, S., S. Jouk, P. Jalbert, et al 1986. DiGeorge syndrome and 22q11 rearrangements. Hum. Genet. 74: 206.
22. Budarf, M.L., J. Collins, W. Gong, et al 1995. Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat. Genet. 10: 269-278.
23. Yamagishi, H., V. Garg, R. Matsuoka, et al 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science. 283: 1158-1161.
24. Lindsay, E.A., A. Botta, V. Jurecic, et al 1999. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature. 401: 379-383.
25. Magnaghi, P., C. Roberts, S. Lorain, et al 1998. HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Nat. Genet. 20: 74-77.
26. Jerome, L.A. & V.E. Papaioannou 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27: 286-291.
27. Yagi, H., Y. Furutani, H. Hamada, et al 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet. 362: 1366-1373.
28. Baldini, A. 2003. DiGeorge's syndrome: a gene at last. Lancet. 362: 1342-1343.
29. Lindsay, E.A. 2001. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2: 858-868.
30. Kelly, R.G., L.A. Jerome-Majewska & V.E. Papaioannou 2004. The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis. Hum. Mol. Genet. 13: 2829-2840.
31. Vitelli, F., M. Morishima, I. Taddei, et al 2002. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum. Mol. Genet. 11: 915-922.
32. Xu, H., F. Cerrato & A. Baldini 2005. Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development. 132: 4387-4395.
33. Ivins, S., K. Lammerts Van Beuren, C. Roberts, et al 2005. Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Dev. Biol. 285: 554-569.
34. Garg, V., C. Yamagishi, T. Hu, et al 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev. Biol. 235: 62-73.
35. Scire, G., B. Dallapiccola, P. Iannetti, et al 1994. Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am. J. Med. Genet. 52: 478-482.
36. Sykes, K.S., L.K. Bachrach, J. Siegel-Bartelt, et al 1997. Velocardiofacial syndrome presenting as hypocalcemia in early adolescence. Arch. Pediatr. Adolesc. Med. 151: 745-747.
37. Bilous, R.W., G. Murty, D.B. Parkinson, et al 1992. Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N. Engl. J. Med. 327: 1069-1074.
38. Thakker, R.V. 2008. GATA3 and hypoparathyroidism, deafness and renal dysplasia. In Inborn Errors of Development. 2nd ed. C.J. Epstein, R.P. Erickson & A.J. Wynshaw-Boris, Eds.: 1055-1060. Oxford University Press. New York.
39. Van Esch, H., P. Groenen, M.A. Nesbit, et al 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature. 406: 419-422.
40. Nesbit, M.A., M.R. Bowl, B. Harding, et al 2004. Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J. Biol. Chem. 279: 22624-22634.
41. Zahirieh, A., M.A. Nesbit, A. Ali, et al 2005. Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J. Clin. Endocrinol. Metab. 90: 2445-2450.
42. Ali, A., P.T. Christie, I.V. Grigorieva, et al 2007. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Hum. Mol. Genet. 16: 265-275.
43. Gaynor, K.U., I.V. Grigorieva, M.A. Nesbit, et al 2009. A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome. J. Clin. Endocrinol. Metab. 94: 3897-3904.
44. Tsang, A.P., J.E. Visvader, C.A. Turner, et al 1997. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell. 90: 109-119.
45. Pandolfi, P.P., M.E. Roth, A. Karis, et al 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11: 40-44.
46. Van Der Wees, J., M.A. Van Looij, M.M. De Ruiter, et al 2004. Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder. Neurobiol. Dis. 16: 169-178.
47. Van Looij, M.A., H. Van Der Burg, R.S. Van Der Giessen, et al 2005. GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice. Neurobiol. Dis. 20: 890-897.
48. Grigorieva, I.V., S. Mirczuk, K.U. Gaynor, et al 2010. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2. J. Clin. Invest. 120: 2144-2155.
49. Lim, K.C., G. Lakshmanan, S.E. Crawford, et al 2000. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 25: 209-212.
50. Grote, D., A. Souabni, M. Busslinger, et al 2006. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development. 133: 53-61.
51. Grote, D., S.K. Boualia, A. Souabni, et al 2008. Gata3 acts downstream of beta-catenin signaling to prevent ectopic metanephric kidney induction. PLoS Genet. 4: e1000316.
52. Gunther, T., Z.F. Chen, J. Kim, et al 2000. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 406: 199-203.
53. Liu, Z., A. Farley, L. Chen, et al 2010. Thymus-associated parathyroid hormone has two cellular origins with distinct endocrine and immunological functions. PLoS Genet. 6: e1001251.
54. Gordon, J., A.R. Bennett, C.C. Blackburn, et al 2001. Gcm2 and Foxn1 mark early parathyroid- and thymus-specific domains in the developing third pharyngeal pouch. Mech. Dev. 103: 141-143.
55. Su, D., S. Ellis, A. Napier, et al 2001. Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis. Dev. Biol. 236: 316-329.
56. Mizobuchi, M., C.S. Ritter, I. Krits, et al 2009. Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J. Bone Miner. Res. 24: 1173-1179.
57. Canaff, L., X. Zhou, I. Mosesova, et al 2009. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Hum. Mutat. 30: 85-92.
58. Ding, C., B. Buckingham & M.A. Levine 2001. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J. Clin. Invest. 108: 1215-1220.
59. Baumber, L., C. Tufarelli, S. Patel, et al 2005. Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism. J. Med. Genet. 42: 443-448.
60. Mannstadt, M., G. Bertrand, M. Muresan, et al 2008. Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J. Clin. Endocrinol. Metab. 93: 3568-3576.
61. Bowl, M.R., S.M. Mirczuk, I.V. Grigorieva, et al 2010. Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism. Hum. Mol. Genet. 19: 2028-2038.
62. Mirczuk, S.M., M.R. Bowl, M.A. Nesbit, et al 2010. A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism. J. Clin. Endocrinol. Metab. 95: 3512-3516.
63. Peden, V. 1960. True idiopathic hypoparathyroidism as a sex-linked recessive trait. Am. J. Hum. Genet. 12: 323-337.
64. Whyte, M. & V. Weldon 1981. Idiopathic hypoparathyroidism presenting with seizures during infancy: x-linked recessive inheritance in a large Missouri kindred. J. Pediatr. 99: 628-611.
65. Whyte, M., G. Kim & M. Kosanovich 1986. Absence of parathyroid tissue in sex-linked recessive hypoparathyroidism. J. Pediatr. 109: 915.
66. Thakker, R.V., K.E. Davies, M.P. Whyte, et al 1990. Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J. Clin. Invest. 86: 40-45.
67. Bowl, M., M. Nesbit, B. Harding, et al 2005. An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism. J. Clin. Invest. 115: 2822-2831.
68. Solomon, N.M., S.A. Ross, T. Morgan, et al 2004. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J. Med. Genet. 41: 669-678.
69. Rizzoti, K., S. Brunelli, D. Carmignac, et al 2004. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat. Genet. 36: 247-255.
70. Collignon, J., S. Sockanathan, A. Hacker, et al 1996. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development. 122: 509-520.
71. Kleinjan, D.A. & V. Van Heyningen 2005. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76: 8-32.
72. Ahonen, P., S. Myllarniemi, I. Sipila, et al 1990. Clinical variation of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322: 1829-1836.
73. Ahonen, P. 1985. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin. Genet. 27: 535-542.
74. Zlotogora, J. & M.S. Shapiro 1992. Polyglandular autoimmune syndrome type I among Iranian Jews. J. Med. Genet. 29: 824-826.
75. Aaltonen, J., P. Bjorses, L. Sandkuijl, et al 1994. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat. Genet. 8: 83-87.
76. Nagamine, K., P. Peterson, H.S. Scott, et al 1997. Positional cloning of the APECED gene. Nat. Genet. 17: 393-398.
77. Pearce, S.H., T. Cheetham, H. Imrie, et al 1998. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am. J. Hum. Genet. 63: 1675-1684.
78. Scott, H.S., M. Heino, P. Peterson, et al 1998. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol. Endocrinol. 12: 1112-1119.
79. Rosatelli, M.C., A. Meloni, M. Devoto, et al 1998. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum. Genet. 103: 428-434.
80. Bjorses, P., M. Halonen, J.J. Palvimo, et al 2000. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 66: 378-392.
81. Liston, A., S. Lesage, J. Wilson, et al 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350-354.
82. Meager, A., K. Visvalingam, P. Peterson, et al 2006. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3: e289.
83. Alimohammadi, M., P. Bjorklund, A. Hallgren, et al 2008. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N. Engl. J. Med. 358: 1018-1028.
84. Eisenbarth, S.C., O.R. Colegio, W. O'connor, et al 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 453: 1122-1126.
85. Hubert, F.X., S.A. Kinkel, P.E. Crewther, et al 2009. Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J. Immunol. 182: 3902-3918.
86. Krumlauf, R. 1994. Hox genes in vertebrate development. Cell. 78: 191-201.
87. Chisaka, O. & M.R. Capecchi 1991. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature. 350: 473-479.
88. Kameda, Y., Y. Arai, T. Nishimaki, et al 2004. The role of Hoxa3 gene in parathyroid gland organogenesis of the mouse. J. Histochem. Cytochem. 52: 641-651.
89. Manley, N.R., L. Selleri, A. Brendolan, et al 2004. Abnormalities of caudal pharyngeal pouch development in Pbx1 knockout mice mimic loss of Hox3 paralogs. Dev. Biol. 276: 301-312.
90. Dietrich, S. & P. Gruss 1995. Undulated phenotypes suggest a role of Pax-1 for the development of vertebral and extravertebral structures. Dev. Biol. 167: 529-548.
91. Neubuser, A., H. Koseki & R. Balling. 1995. Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1. Dev. Biol. 170: 701-716.
92. Wallin, J., H. Eibel, A. Neubuser, et al 1996. Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation. Development. 122: 23-30.
93. Peters, H., A. Neubuser, K. Kratochwil, et al 1998. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev. 12: 2735-2747.
94. Xu, P.X., W. Zheng, C. Laclef, et al 2002. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development. 129: 3033-3044.
95. Zou, D., D. Silvius, J. Davenport, et al 2006. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev. Biol. 293: 499-512.
96. Deutsch, U., G.R. Dressler & P. Gruss 1988. Pax 1, a member of a paired box homologous murine gene family, is expressed in segmented structures during development. Cell. 53: 617-625.
97. Chi, N. & J.A. Epstein 2002. Getting your Pax straight: pax proteins in development and disease. Trends Genet. 18: 41-47.
98. Peters, H., A. Neubuser & R. Balling 1998. Pax genes and organogenesis: Pax9 meets tooth development. Eur. J. Oral Sci. 106(Suppl 1): 38-43.
99. Griffith, A.V., K. Cardenas, C. Carter, et al 2009. Increased thymus- and decreased parathyroid-fated organ domains in Splotch mutant embryos. Dev. Biol. 327: 216-227.
100. Hol, F.A., M.P. Geurds, S. Chatkupt, et al 1996. PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. J. Med. Genet. 33: 655-660.
101. Baldwin, C.T., N.R. Lipsky, C.F. Hoth, et al 1994. Mutations in PAX3 associated with Waardenburg syndrome type I. Hum. Mutat. 3: 205-211.
102. Das, P., M. Hai, C. Elcock, et al 2003. Novel missense mutations and a 288-bp exonic insertion in PAX9 in families with autosomal dominant hypodontia. Am. J. Med. Genet. A. 118A: 35-42.
103. Bonini, N.M., W.M. Leiserson & S. Benzer 1993. The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell. 72: 379-395.
104. Abdelhak, S., V. Kalatzis, R. Heilig, et al 1997. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat. Genet. 15: 157-164.
105. Misra, M. & K.D. Nolph 1998. Renal failure and deafness: branchio-oto-renal syndrome. Am. J. Kidney Dis. 32: 334-337.
106. Smith, R.J. & C. Schwartz 1998. Branchio-oto-renal syndrome. J. Commun. Disord. 31: 411-420.
107. Kalatzis, V., I. Sahly, A. El-Amraoui, et al 1998. Eya1 expression in the developing ear and kidney: towards the understanding of the pathogenesis of Branchio-Oto-Renal (BOR) syndrome. Dev. Dyn. 213: 486-499.
108. Xu, P.X., J. Adams, H. Peters, et al 1999. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat. Genet. 23: 113-117.
109. Ohto, H., S. Kamada, K. Tago, et al 1999. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol. Cell Biol. 19: 6815-6824.
110. Buller, C., X. Xu, V. Marquis, et al 2001. Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. Hum. Mol. Genet. 10: 2775-2781.
111. Ruf, R.G., P.X. Xu, D. Silvius, et al 2004. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc. Natl Acad. Sci. U.S.A. 101: 8090-8095.
112. Kameda, Y., N. Watari-Goshima, T. Nishimaki, et al 2003. Disruption of the Hoxa3 homeobox gene results in anomalies of the carotid artery system and the arterial baroreceptors. Cell Tissue Res. 311: 343-352.
113. Abdelhak, S., V. Kalatzis, R. Heilig, et al 1997. Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum. Mol. Genet. 6: 2247-2255.
114. Thomee, C., S.W. Schubert, J. Parma, et al 2005. GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J. Clin. Endocrinol. Metab. 90: 2487-2492.